New sugar-based permeant analogs of D-Myo-inositol 1,4,5-trisphosphate mimicking the effect of vasopressin: Synthesis and biologic evaluation

Journal of Carbohydrate Chemistry

Volumn 24, Issue 4-6, 2005, Pages 549-581

  Chrétien, Françoise ^a   Roussel, Fabien ^a   Hilly, Mauricette ^b   Mauger, Jean Pierre ^b   Chapleur, Yves ^a  

^a NANCY UNIVERSITÉ   (France)

^b INSERM   (France)

Author keywords

Calcium liberation; Carbohydrate; Cell; Inositol 1,4,5 trisphosphate; Permeant analogs; Vasopressin

Indexed keywords

EID: 27844528534     PISSN: 07328303     EISSN: 15322327     Source Type: Journal    
DOI: 10.1081/CAR-200068070     Document Type: Article

References (91)

1. Rasmussen, H. Cell communication, calcium ion, and cyclic adenosine monophosphate. Science 1970, 170, 404-412.
2. Putney, J.W.J. Inositol Phosphate and Calcium Signalling; Raven Press: New York, 1992.
3. Chi, T.H.; Crabtree, G.R. Signal transduction - Inositol phosphates in the nucleus. Science 2000, 287, 1937.
4. Michell, R.H. Inositol phospholipids and cell surface receptor function. Biochim. Biophys. Acta 1975, 415, 81-147.
5. Streb, H.; Irvine, R.F.; Berridge, M.J.; Schulz, I. Release of calcium(2+) from a non-mitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983, 306, 67-69.
6. (a) Berridge, M.J.; Irvine, R.F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984, 312, 315-321;
7. (b) Berridge, M.J. Inositol trisphosphate and diacylglycerol two interacting second messengers. Annu. Rev. Biochem. 1987, 56, 159-193;
8. (c) Berridge, M.J.; Irvine, R.F. Inositol phosphates and cell signalling. Nature 1989, 341, 197-203;
9. (d) Berridge, M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361, 315-325.
10. Taylor, C.W.; Richardson, A. Structure and function of inositol trisphosphate receptors. Pharmac. Ther. 1991, 51, 97-137.
11. (a) Billington, D.C. Recent developments in the synthesis of myo-inositol phosphates. Chem. Soc. Rev. 1989, 18, 83-122;
12. (b) Potter, B.V.L. Recent advances in the chemistry and biochemistry of inositol phosphates of biological interest. Nat. Prod. Reports 1990, 1-24;
13. (c) Potter, B.V.L.; Nahorski, S.R. Synthetic inositol polyphosphates and analogues as molecular probes for neuronal second messengers receptors. In Drug Design for Neuroscience; Kozikowski, A.P., Ed.; Raven Press, 1993; Vol. 14, 383-416;
14. (d) Potter, B.V.L.; Lampe, D. Chemistry of inositol lipid mediated cellular signaling. Angew. Chem. Int. Ed. Engl. 1995, 34, 1933-1972;
15. (e) Poirot, E.; Bourdon, H.; Chrétien, F.; Chapleur, Y.; Berton, B.; Hilly, M.; Mauger, J.-P.; Guillon, G. Influence of the absolute configuration at C-4 in the binding of D-myo-inositol 1,4,5-trisphosphate analogues to IP3 receptors. Bioorg. Med. Chem. Lett. 1995, 5, 569-572;
16. (f) Wilcox, R.A.; Primrose, W.U.; Nahorski, S.; Chaliss, R.A.J. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. TIPS 1998, 19, 467-475;
17. (g) Jenkins, D.J.; Riley, A.M.; Potter, B.V.L. Carbohydrates as sources of chiral inositols polyphosphates and their mimics. In Carbohydrate Mimics; Chapleur, Y., Ed.; 1998; 171-208.
18. Chrétien, F.; Moitessier, N.; Roussel, F.; Mauger, J.P.; Chapleur, Y. Carbohydrate - based mimics of D-myo-inositol 1,4,5- trisphosphate. Curr. Org. Chem. 2000, 4, 513-534.
19. Moris, M.-A.; Caron, A.Z.; Guillemette, G.; Schlewer, G. Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate). Bioorg. Med. Chem. 2004, 12, 3995-4001.
20. Moitessier, N.; Chrétien, F.; Chapleur, Y.; Humeau, C. Synthesis and biological activities of inositol 1, 4, 5-trisphosphate mimics related to xylopyranosides-Tetrahedron Lett. 1995, 36, 8023-8026.
21. Moitessier, N.; Chrétien, F.; Chapleur, Y. Asymmetric dihydroxylation of D-xylose - derived allyl ethers. Tetrahedron-Asymmetry 1997, 6, 2889-2892.
22. Roussel, F.; Hilly, M.; Chrétien, F.; Mauger, J.-P.; Chapleur, Y. Synthesis of 2-hydroxy ethyl 2-deoxy-a-D-threo pyranoside 3,4,2′- trisphosphate, a mimic of the second messenger inositol 1,4,5-trisphosphate. J. Carbohydr. Chem. 1999, 18, 697-707.
23. Rosenberg, H.J.; Riley, A.M.; Marwood, R.D.; Correa, V.; Taylor, C.W.; Potter, B.V.L. Xylopyranoside-based agonists of D-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity. Carbohydr. Res. 2001, 332, 53-66.
24. Roussel, F.; Moitessier, N.; Hilly, M.; Chrétien, F.; Mauger, J.-P.; Chapleur, Y. D-myo-inositol-1,4,5-trisphosphate and adenophostin mimics: importance of the spacial orientation of a phosphate groupe on the biological activity. Bioorg. Med. Chem. 2002, 10, 759-768.
25. (a) Takahashi, S.; Kinoshita, T.; Takahashi, M. Adenophostins A and B: potent agonists of inositol-1,4,5-trisphosphate receptor produced by Penicillium brevicompactum. Structure elucidation.. J. Antibiotics 1994, 47, 95-100;
26. (b) Takahashi, M.; Tanzawa, K.; Takahashi, S. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 1994, 289, 369-372.
27. (a) Hotoda, H.; Takahashi, M.; Tanzawa, K.; Takahashi, S.; Kaneko, M. IP3 receptor-ligand. 1. Synthesis of adenophostin A. Tetrahedron Lett. 1995, 36, 5037-5040;
28. (b) van Straten, N.C.R.; van der Marel, G.A.; van Boom, J.H. An expeditious route to the synthesis of adenophostin A. Tetrahedron Lett. 1996, 37, 3599-3602;
29. (c) van Straten, N.C.R.; van der Marel, G.A.; van Boom, J.H. An expeditious route to the synthesis of adenophostin A. Tetrahedron 1997, 53, 6509-6522;
30. (d) Marwood, R.D.; Riley, A.M.; Jenkins, D.J.; Potter, B.V.L. Synthesis of adenophostin A and congeners modified at glucose. J. Chem. Soc., Perkin Trans. 1 2000, 1935-1947;
31. (e) Marwood, R.D.; Correa, V.; Taylor, C.W.; Potter, B.V.L. Synthesis of adenophostin A. Tetrahedron-Asymmetry 2000, 11, 397-403.
32. (a) Jenkins, D.J.; Potter, B.V.L. (2-hydroxyethyl)-alpha-D- Glucopyranoside-2′-3,4-trisphosphates: synthesis of a second messenger mimic related to adenophostin A. J. Chem. Soc., Chem. Commun. 1995, 1169;
33. (b) Jenkins, D.J.; Potter, B.V.L. A Ca2+-mobilising carbohydrate-based polyphosphate: synthesis of 2-hydroxyethyl alpha-D-glucopyranoside 2′,3,4-trisphosphate. Carbohydr. Res. 1996, 287, 169-182;
34. (c) Jenkins, D.J.; Marwood, R.D.; Potter, B.V.L. A disaccharide polyphosphate mimic of 1D-myo-inositol 1,4,5- trisphosphate. Chem. Commun. 1997, 449-450;
35. (d) van Straten, N.C.R.; van der Marel, G.A.; van Boom, J.H. Synthesis of 2′,3″,4″-trisphosphate-containing analogs of adenophostin A. Tetrahedron 1997, 53, 6523-6538;
36. (e) van Straten, N.C.R.; Kriek, N.M.A.J.; Cziria, Z.A.C.; van der Marel, G.A.; van Boom, J.H. Synthesis of 3″,4″-bisphosphate-containing analogs of adenophostin A. Tetrahedron 1997, 53, 6539-6554;
37. (f) de Kort, M.; Valentijn, A.R.P.M.; van der Marel, G.A.; van Boom, J.H. Synthesis of clustered disaccharide polyphosphate analogues of adenophostin A. Tetrahedron Lett. 1997, 38, 7629-7632;
38. (g) Shuto, S.; Tatani, K.; Ueno, Y.; Matsuda, A. Synthesis of adenophostin analogues lacking the adenine moiety as novel potent IP3 receptor ligands: some structural requirements for the significant activity of adenophostin A. J. Org. Chem. 1998, 63, 8815-8824;
39. (h) Tatani, K.; Shuto, S.; Ueno, Y.; Matsuda, A. Synthesis of 1-O-[(3S,4R)-3-hydroxytetrahydrofuran-4-yl]- alpha-D - gluco-pyranoside 3,4,3′-trisphosphate as a novel potent IP3 receptor ligand. Tetrahedron Lett. 1998, 39, 5065-5068;
40. (i) Riley, A.M.; Potter, B.V.L. Bicyclic analogues of inositol 1,4,5-trisphosphate based upon adenophostin A. Tetrahedron Lett. 1999, 40, 2213-2216;
41. (j) Marwood, R.D.; Riley, A.M.; Correa, V.; Taylor, C.W.; Potter, B.V. Simplification of adenophostin A defines a minimal structure for potent glucopyranoside-based mimics of D-myo-inositol 1,4,5-trisphosphate. Bioorg. Med. Chem. Lett 1999, 9, 453-458;
42. (k) Abe, H.; Shuto, S.; Matsuda, A. Synthesis of the C-glycosidic analog of adenophostin A, a potent IP3 receptor agonist, using a temporary silicon- tethered radical coupling reaction as the key step. Tetrahedron Lett. 2000, 41, 2391-2394;
43. (l) Abe, H.; Shuto, S.; Matsuda, A. Synthesis of the C-glycosidic analogue of adenophostin A and its uracil congener as potential IP3 receptor ligands. Stereoselective construction of the C-glycosidic structure by a temporary silicon-tethered radical coupling reaction. J. Org. Chem. 2000, 65, 4315-4325;
44. (m) Shuto, S.; Yahiro, Y.; Ichikawa, S.; Matsuda, A. Synthesis of 3,7-anhydro-D-glycero-D-ido-octitol 1,5,6- trisphosphate as an IP3 receptor ligand using a radical cyclization reaction with a vinylsilyl tether as the key step. Conformational restriction strategy using steric repulsion between adjacent bulky protecting groups on a pyranose ring. J. Org. Chem. 2000, 65, 5547-5557;
45. (n) de Kort, M.; Regenbogen, A.D.; Overkleeft, H.S.; Challiss, R.A.J.; Iwata, Y.; Miyamoto, S.; van der Marel, G.A.; van Boom, J.H. Synthesis and biological evaluation of cyclophostin: a 5′,6″-tethered analog of adenophostin A. Tetrahedron 2000, 56, 5915-5928;
46. (o) de Kort, M.; Regenbogen, A.D.; Valentijn, A.R.P.M.; Challiss, R.A.J.; Iwata, Y.; Miyamoto, S.; van der Marcel, G.A.; van Boom, J.H. Spirophostins: conformationally restricted analogues of adenophostin A. Chem. Eur. J. 2000, 6, 2696-2704;
47. (p) de Kort, M.; Luijendijk, J.; van der Marel, G.A.; van Boom, J.H. Synthesis of photoaffinity derivatives of adenophostin A. Eur. J. Org. Chem. 2000, 3085-3092;
48. (q) Shuto, S.; Horne, G.; Marwood, R.D.; Potter, B.V.L. Total synthesis of nucleobase-modified adenophostin A mimics. Chem. Eur. J. 2001, 7, 4937-4946.
49. (a) Hirota, J.; Michikawa, T.; Miayawaki, A.; Takahashi, M.; Tanzawa, K.; Okura, I.; Furuichi, T.; Mikoshiba, K. Adenophostin-medicated quantal Ca2+ release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1. FEBS Lett. 1995, 368, 248-252;
50. (b) Wilcox, R.A.; Erneux, C.; Primrose, W.U.; Gigg, R.; Nahorski, S. 2-hydroxyethyl-a-D-glucopyranoside-2,3′,4′-trisphosphate, a novel metabolically resistant adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor. Mol. Pharmacol. 1995, 47, 1204-1211;
51. (c) Murphy, C.T.; Riley, A.M.; Lindley, C.J.; Jenkins, D.J.; Westwich, J.; Potter, B.V.L. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A/Recognition by cerebellar and platelet inositol-1,4,5- trisphosphate receptors. Mol. Pharmacol. 1997, 52, 741-748;
52. (d) Beecroft, M.D.; Marchant, J.S.; Riley, A.M.; van Straten, N.C.R.; van der Marel, G.A.; van Boom, J.H.; Potter, B.V.L.; Taylor, C.W. Acyclophostin/A ribose modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy. Mol. Pharmacol. 1999, 55, 109-117;
53. (e) De Lisle, S.; Marksberry, E.W.; Bonnett, C.; Jenkins, D.J.; Potter, B.V.L.; Takahashi, M.; Tanzawa, K. Adenophostin A can stimulate Ca2+ influx without depleting the inositol 1,4,5-trisphoshate sensitive Ca2+ stores in the Xenopu oocyte. J. Biol. Chem. 1997, 272, 9956-9961;
54. (f) Marchant, J.S.; Beecroft, M.D.; Riley, A.M.; Jenkins, D.J.; Marwood, R.D.; Taylor, C.W.; Potter, B.V.L. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,′,(-trisphosphate receptors. Biochemistry 1997, 36, 12780-12790;
55. (g) Hotoda, H.; Murayama, K.; Miyamoto, S.; Iwata, Y.; Takahashi, M.; Kawase, Y.; Tanzawa, K.; Kaneko, M. Molecular recognition of adenophostin, a very potent Ca2+ inducer at the D-myo-inositol 1,4,5-trisphosphate receptor. Biochemistry 1999, 38, 9234-9241;
56. (h) Sato, Y.; Miyazaki, S.; Shikano, T.; Mitsuhashi, N.; Takeuchi, H.; Mikoshiba, K.; Kuwabara, Y. Adenophostin a potent agonist of the inositol 1,4,5-trisphosphate receptor is useful for fertilization of mouse oocytes injected with round spermatids leading to normal off spring. Biol. Reprod. 1998, 58, 867-873;
57. (i) Correa, V.; Riley, A.M.; Shuto, S.; Horne, G.; Nerou, E.P.; Marwood, R.D.; Potter, B.V.L.; Taylor, C.W. Structural determinants of adenophostin a activity at inositol trisphosphate receptors. Mol. Pharmacol. 2001, 59, 1206-1215.
58. (a) Roemer, S.; Rudolf, M.T.; Stadler, C.; Schultz, C. Synthesis of D-myo-inositol 3,4,5,6- and 1,4,5,6-tetrakisphosphate analogs and their membrane-permeant derivatives. J. Chem. Soc. Chem. Commun. 1995, 411-412;
59. (b) Roemer, S.; Stadler, C.; Rudolf, M.T.; Jastorff, B.; Schultz, C. Membrane-permeant analogues of the putative second messenger myo-inositol 3,4,5,6-tetrakisphosphate. J. Chem. Soc., Perkin Trans. 1 1996, 1683-1694;
60. (c) Li, W.H.; Schultz, C.; Llopis, J.; Tsien, R.Y. Membrane-permeant esters of inositol polyphosphates, chemical syntheses and biological applications. Tetrahedron 1997, 53, 12017-12040;
61. (d) Li, W.H.; Llopis, J.; Whitney, M.; Zlokarnik, G.; Tsien, R.Y. Cell-permeant caged InsP(3) ester shows that Ca2+ spike frequency can optimize gene expression. Nature 1998, 392, 936-941;
62. (e) Rudolf, M.T.; Traynor-Kaplan, A.E.; Schultz, C. A membrane-permeant, bioactivatable derivative of Ins(1,3,4)P3 and its effect on Cl(-)-secretion from T84 cells. Bioorg. Med. Chem. Lett 1998, 8, 1857-1860;
63. (f) Dubreuil, D.; Cleophax, J.; Viera de Almeida, M.; Verre Sebrie, C.; Pipelier, M.; Vass, G.; Gero, S.D. Stereoselective synthesis of myo-inositol-1,3,4,5- tetrakisphosphate analogues from 6-deoxy D-inositol precursors. Tetrahedron 1999, 55, 7573-7582;
64. (g) de Almeida, M.V.; Cleophax, J.; Gateau-Olesker, A.; Prestat, G.; Dubreuil, D.; Gero, S.D. Synthesis of deoxy phosphatidylinositol analogues and phosphonate isosters of Ins(1,4,5)P-3. Tetrahedron 1999, 55, 12997-13010;
65. (h) de Almeida, M.V.; Dubreuil, D.; Cleophax, J.; VerreSebrie, C.; Pipelier, M.; Prestat, G.; Vass, G.; Gero, S.D. Stereoselective synthesis of inositol mono, bis and trisphosphate analogues from 6-deoxy-D-inositol precursors. Tetrahedron 1999, 55, 7251-7270.
66. Bannwarth, W.; Trzeciak, A. A simple and effective chemical phosphorylation procedure for biomolecules. Helv. Chim. Acta 1987, 70, 175-186.
67. (a) Marugg, J.E.; Tromp, M.; Kuyl-Yeheskiely, E.; van der Marel, G.A.; van Boom, J.H. A convenient and general approach to the synthesis of properly protected d-nucleoside-3′-hydrogenphosphonates via phosphite intermediates. Tetrahedron Lett. 1986, 27, 2661-2664;
68. (b) Knerr, L.; Pannecouke, X.; Schmitt, G.; Luu, B. Preferential phosphorylation at the primary alcohol of non - protected thymidine or carbohydrates. Tetrahedron Lett. 1996, 37, 5123-5126.
69. (a) Garegg, P.J.; Lindh, I.; Regberg, T.; Stawinski, J.; Stroemberg, R.; Henrichson, C. Nucleoside H-phosphonates. III. Chemical synthesis of oligodeoxyribonucleotides by the hydrogenphosphonate approach.. Tetrahedron Lett. 1986, 27, 4051-4054;
70. (b) Froehler, B.C.; Matteucci, M.D. Nucleoside h-phosphonates: valuable intermediates in the synthesis of deoxyoligonucleotides. Tetrahedron Lett. 1986, 27, 469-472.
71. Garegg, P.J.; Regberg, T.; Stawinski, J.; Stroemberg, R. Studies on the synthesis of oligonucleotides via the hydrogen phosphonate approach. Nucleosides & Nucleotides 1987, 6, 283-286.
72. Garegg, P.J.; Regberg, T.; Stawinski, J.; Stroemberg, R. Studies on the oxidation of nucleoside hydrogen phosphonates. Nucleosides & Nucleotides 1987, 6, 429-32.
73. Schultz, C. Prodrugs of biologically active phosphate esters. Bioorg. Med. Chem. 2003, 11, 885-898.
74. (a) Jansen, A.B.A.; Russell, T.J. Novel penicillin derivatives. Chem. Soc. 1965, 2127-2132;
75. (b) Ferres, H. Pro-drugs of b-lactam antibiotics. Chem. Ind. 1980, 435-440;
76. (c) Schultz, C.; Vajanaphanich, M.; Harootunian, A.T.; Sammak, P.J.; Barrett, K.E.; Tsien, R.Y. Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP. J. Biol. Chem. 1993, 268, 6316-6122.
77. Vajanaphanich, M.; Schultz, C.; Rudolf, M.T.; Wasserman, M.; Enyedi, P.; Craxton, A.; Shears, S.B.; Tsien, R.Y.; Barrett, K.E.; Traynor-Kaplan, A. Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4. Nature 1994, 371, 711-714.
78. Bodor, N.; Kaminski, J.J.; Selk, S. Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials. J. Med. Chem. 1980, 23, 469-474.
79. Bedford, C.D.; Harris, R.N.I.; Howd, R.A.; Goff, D.A.; Koolpe, G.A.; Petesch, M.; Miller, A.; Nolen, H.W.I.; Musallam, H.A.; Pick, R.O.; Jones, D.E.; Koplovitz, I.; Sultan, W.E.. Quaternary salts of 2-[(hydroxyimino)methyl] imidazole. 2. Preparation and in vitro and in vivo evaluaton of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimidazolium halides for reactivation of organophosphorus-inhibited acetylcholinesteases. J. Med. Chem. 1989, 32, 493-503.
80. Grynkiewicz, G.; Tsien, R.Y. Preparation of acyloxymethyl halides from acylals. Pol. J. Chem. 1987, 61, 443-447.
81. (a) Prestwich, G.D.; Marecek, J.F.; Mourey, R.J.; Theibert, A.B.; Ferris, C.D.; Danoff, S.K.; Snyder, S.H. Tethered IP3. Synthesis and biochemical applications of the 1-O-(3-aminopropyl) ester of inositol 1,4,5-trisphosphate. J. Am. Chem. Soc. 1991, 113, 1822-1825;
82. (b) Prestwich, G.D. Touching all the bases: synthesis of inositol polyphosphate and phosphoinositide affinity probes from glucose. Acc. Chem. Res. 1996, 29, 503-513.
83. (a) Mourey, R.J.; Estevez, V.A.; Marecek, J.F.; Barrow, R.K.; Prestwich, G.D.; Synder, S.H. Inositol 1,4,5-trisphosphate receptors: labelling the inositol 1,4,5-trisphosphate binding site with photoaffinity ligands. Biochemistry 1993, 32, 1719-1726;
84. (b) Dorman, G.; Prestwich, G.D. Benzophenone photophores in biochemistry. Biochemistry 1994, 33, 5661-5673.
85. Jenkins, D.J.; Potter, B.V.L. Total synthesis, from D-xylose, of chiral, ring-contracted 1D-myo-inositol 1,4,5-trisphosphate and 1,3,4,5- tetrakisphosphate analogues with C-2 excised. J. Chem. Soc. Perkin Trans. 1 1998, 41-49.
86. Ram, S.; Spicer, L.D. Reduction of aldehydes and ketones to methylen derivatives using ammonium formate as a catalytic hydrogen transfer agent. Tetrahedron Lett. 1988, 29, 3741-3744.
87. Inoue, T.; Kikuchi, K.; Hirose, K.; Iino, M.; Nagano, T. Synthesis and evaluation of 1-position-modified inositol 1,4,5- trisphosphate analogs. Bioorg. Med. Chem. Lett 1999, 9, 1697-1702.
88. Williamson, J.R.; Cooper, R.H.; Joseph, S.K.; Thomas, A.P. Inositol trisphosphate and diacylglycerol as intracellular second messengers in liver. Am. J. Physiol. 1985, 248, C203-C216.
89. Putney, J.W.J.; Broad, L.M.; Braun, F.J.; Lievremont, J.P.; Bird, G.S. Mechanisms of capacitative calcium entry. J. Cell Sci. 2001, 114, 2223-2229.
90. Seglen, P.O. Preparation of isolated rat liver cells. Meth. Cell. Biol 1976, 13, 29-83.
91. Tordjmann, T.; Berthon, B.; Claret, M.; Combettes, L. Coordinated intercellular calcium waves induced by noradrenaline in rat hepatocytes: dual control by gap junction permeability and agonist. EMBO J. 1997, 16, 5398-5407.